{Reference Type}: Journal Article
{Title}: Long-Term Results of Transscleral Diode Laser Cyclophotocoagulation in Glaucoma: A Real-Life Study.
{Author}: Sari C;Alagoz N;Omeroglu A;Cakir I;Pasaoglu I;Altan C;Yasar T;
{Journal}: J Glaucoma
{Volume}: 33
{Issue}: 6
{Year}: 2024 Jun 1
{Factor}: 2.29
{DOI}: 10.1097/IJG.0000000000002346
{Abstract}: <B>CONCLUSIONS: </B>Transscleral diode laser cyclophotocoagulation (TDLC) is effective and safe in a large population and different types of glaucoma but is least effective in the neovascular glaucoma (NVG) group.<BR><B>OBJECTIVE: </B>We aimed to investigate the clinical outcomes of TDLC in a large cohort of patients with different types of refractory glaucoma.<BR><B>METHODS: </B>Using patient charts, we retrospectively analyzed the success and complications of TDLC performed on eyes categorized into 6 groups: primary glaucoma (116 eyes), trauma (41 eyes), NVG (84 eyes), post-vitreoretinal surgery (post-VRS, 79 eyes), penetrating keratoplasty (47 eyes), and miscellaneous (40 eyes). Failure was defined as intraocular pressure (IOP) >22 mm Hg or <5 mm Hg, the need for further glaucoma surgery, and the loss of light perception during follow-up.<BR><B>RESULTS: </B>Overall, the mean follow-up time was 33.4 ± 17.4 months, the mean total energy delivered was 109.2 ± 56.5 J, and the mean IOP reduction rate was 41.8%. Total energy delivered and IOP reduction rates were similar between the groups (all P > 0.05). The probability of success at 36 months was 71.5%, 70.7%, 55.9%, 77.2%, 72.3%, and 72.5% in primary glaucoma, trauma, NVG, post-VRS, penetrating keratoplasty, and miscellaneous groups, respectively. The NVG group showed a significantly lower success rate ( P = 0.009) than the other groups. Significant complications consisted of phthisis bulbi in 1 eye (0.2%) in the NVG group and chronic hypotony in 7 eyes (1.7%) in the NVG (3 eyes), trauma (2 eyes), post-VRS (1 eye), and primary glaucoma (1 eye) groups.<BR><B>CONCLUSIONS: </B>Although TDLC was found to be a safe, effective method in the long term, it was least effective in eyes with NVG.